company

Novo Nordisk

Novo Nordisk is a company that announced a $200 million commitment to the World Diabetes Foundation on November 11, 2026, covering 2027 through 2036.

Grants and gifts by Novo Nordisk

Recipient	Amount	Announced	Purpose
World Diabetes Foundation Read the story	$200 million	Nov 11, 2026	Diabetes prevention and care in low- and middle-income countries, 2027 through 2036

Key facts

Commitment to the World Diabetes Foundation: USD 200 million for 2027 through 2036source
Announcement date: 11 November 2026, ahead of World Diabetes Day (14 November)source
Release dateline: Bagsværd, Denmarksource

WYDE coverage of Novo Nordisk

WYDE Newsroom has published one article about Novo Nordisk, on Nov 11, 2026. Novo Nordisk is a donor in 1 story. The most recent is Novo Nordisk's $200 Million to World Diabetes Foundation Averages $20 Million a Year.

Healthcare

Novo Nordisk's $200 Million to World Diabetes Foundation Averages $20 Million a Year

Novo Nordisk committed $200 million to the World Diabetes Foundation for 2027 through 2036. Spread across the 10 years, the commitment averages $20 million a year.

Nov 11, 2026 · 3 min read · Donor

Reported alongside Novo Nordisk

World Diabetes Foundation · in 1 story with Novo Nordisk

Sources

The Manila Times: Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care

Track the institutions that move money.

Data-driven coverage, every week.